Incretins and bone: Friend or foe?

Current Opinion in Pharmacology

Volumn 22, Issue , 2015, Pages 72-78

  Mabilleau, Guillaume ^a,b  

^a UNIV Angers   (France)

^b LUNAM Universite   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; INCRETIN; HORMONE;

BONE DENSITY; BONE MASS; BONE MINERALIZATION; BONE STRENGTH; CELL PROLIFERATION; CORTICAL THICKNESS (BONE); EXON; GENE; GENE EXPRESSION; GENE LOCATION; GIP GENE; GLP1R GENE; HORMONE RESPONSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVIEW; ANIMAL; BONE; BONE REMODELING; HUMAN; METABOLISM; PHYSIOLOGY;

ANIMALS; BONE AND BONES; BONE REMODELING; HORMONES; HUMANS; INCRETINS;

EID: 84928485190     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2015.03.007     Document Type: Review

References (71)

1. M. Ferron, E. Hinoi, G. Karsenty, and P. Ducy Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice Proc Natl Acad Sci U S A 105 2008 5266 5270
2. M. Ferron, M.D. McKee, R.L. Levine, P. Ducy, and G. Karsenty Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice Bone 50 2012 568 575
3. F. Oury, M. Ferron, W. Huizhen, C. Confavreux, L. Xu, J. Lacombe, P. Srinivas, A. Chamouni, F. Lugani, and H. Lejeune Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis J Clin Invest 123 2013 2421 2433
4. L.D. Quarles Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism Nat Rev Endocrinol 8 2012 276 286
5. D. Chappard, M.F. Basle, E. Legrand, and M. Audran New laboratory tools in the assessment of bone quality Osteoporos Int 22 2011 2225 2240
6. C. Hamilton, and D.L. Seidner Metabolic bone disease and parenteral nutrition Curr Gastroenterol Rep 6 2004 335 341
7. D.B. Henriksen, P. Alexandersen, N.H. Bjarnason, T. Vilsboll, B. Hartmann, E.E. Henriksen, I. Byrjalsen, T. Krarup, J.J. Holst, and C. Christiansen Role of gastrointestinal hormones in postprandial reduction of bone resorption J Bone Miner Res 18 2003 2180 2189
8. F. Li, and R.C. Muhlbauer Food fractionation is a powerful tool to increase bone mass in growing rats and to decrease bone loss in aged rats: modulation of the effect by dietary phosphate J Bone Miner Res 14 1999 1457 1465
9. W. Creutzfeldt The incretin concept today Diabetologia 16 1979 75 85
10. D.J. Drucker The biology of incretin hormones Cell Metab 3 2006 153 165
11. Y. Higashimoto, E.C. Opara, and R.A. Liddle Dietary regulation of glucose-dependent insulinotropic peptide (GIP) gene expression in rat small intestine Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 110 1995 207 214
12. C.C. Tseng, L.A. Jarboe, and M.M. Wolfe Regulation of glucose-dependent insulinotropic peptide gene expression by a glucose meal Am J Physiol 266 1994 G887 G891
13. N. Inagaki, Y. Seino, J. Takeda, H. Yano, Y. Yamada, G.I. Bell, R.L. Eddy, Y. Fukushima, M.G. Byers, and T.B. Shows Gastric inhibitory polypeptide: structure and chromosomal localization of the human gene Mol Endocrinol 3 1989 1014 1021
14. J. Takeda, Y. Seino, K. Tanaka, H. Fukumoto, T. Kayano, H. Takahashi, T. Mitani, M. Kurono, T. Suzuki, and T. Tobe Sequence of an intestinal cDNA encoding human gastric inhibitory polypeptide precursor Proc Natl Acad Sci U S A 84 1987 7005 7008
15. R. Ugleholdt, M.L. Poulsen, P.J. Holst, J.C. Irminger, C. Orskov, J. Pedersen, M.M. Rosenkilde, X. Zhu, D.F. Steiner, and J.J. Holst Prohormone convertase 1/3 is essential for processing of the glucose-dependent insulinotropic polypeptide precursor J Biol Chem 281 2006 11050 11057
16. L.L. Baggio, and D.J. Drucker Biology of incretins: GLP-1 and GIP Gastroenterology 132 2007 2131 2157
17. C.H. McIntosh, S. Widenmaier, and S.J. Kim Glucose-dependent insulinotropic polypeptide (Gastric Inhibitory Polypeptide; GIP) Vitam Horm 80 2009 409 471
18. A.M. Buchan, J.M. Polak, C. Capella, E. Solcia, and A.G. Pearse Electronimmunocytochemical evidence for the K cell localization of gastric inhibitory polypeptide (GIP) in man Histochemistry 56 1978 37 44
19. S. Sykes, L.M. Morgan, J. English, and V. Marks Evidence for preferential stimulation of gastric inhibitory polypeptide secretion in the rat by actively transported carbohydrates and their analogues J Endocrinol 85 1980 201 207
20. Y. Yamada, T. Hayami, K. Nakamura, P.J. Kaisaki, Y. Someya, C.Z. Wang, S. Seino, and Y. Seino Human gastric inhibitory polypeptide receptor: cloning of the gene (GIPR) and cDNA Genomics 29 1995 773 776
21. S. Gremlich, A. Porret, E.H. Hani, D. Cherif, N. Vionnet, P. Froguel, and B. Thorens Cloning, functional expression, and chromosomal localization of the human pancreatic islet glucose-dependent insulinotropic polypeptide receptor Diabetes 44 1995 1202 1208
22. T.B. Usdin, E. Mezey, D.C. Button, M.J. Brownstein, and T.I. Bonner Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain Endocrinology 133 1993 2861 2870
23. R.H. Eckel, W.Y. Fujimoto, and J.D. Brunzell Gastric inhibitory polypeptide enhanced lipoprotein lipase activity in cultured preadipocytes Diabetes 28 1979 1141 1142
24. K. Miyawaki, Y. Yamada, N. Ban, Y. Ihara, K. Tsukiyama, H. Zhou, S. Fujimoto, A. Oku, K. Tsuda, and S. Toyokuni Inhibition of gastric inhibitory polypeptide signaling prevents obesity Nat Med 8 2002 738 742
25. T. Wasada, K. McCorkle, V. Harris, K. Kawai, B. Howard, and R.H. Unger Effect of gastric inhibitory polypeptide on plasma levels of chylomicron triglycerides in dogs J Clin Invest 68 1981 1106 1107
26. M.C. Althage, E.L. Ford, S. Wang, P. Tso, K.S. Polonsky, and B.M. Wice Targeted ablation of glucose-dependent insulinotropic polypeptide-producing cells in transgenic mice reduces obesity and insulin resistance induced by a high fat diet J Biol Chem 283 2008 18365 18376
27. V.A. Gault, N. Irwin, B.D. Green, J.T. McCluskey, B. Greer, C.J. Bailey, P. Harriott, F.P. O'Harte, and P.R. Flatt Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes Diabetes 54 2005 2436 2446
28. N. Irwin, P.L. McClean, F.P. O'Harte, V.A. Gault, P. Harriott, and P.R. Flatt Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice Diabetologia 50 2007 1532 1540
29. J. Nyberg, M.F. Anderson, B. Meister, A.M. Alborn, A.K. Strom, A. Brederlau, A.C. Illerskog, O. Nilsson, T.J. Kieffer, and M.A. Hietala Glucose-dependent insulinotropic polypeptide is expressed in adult hippocampus and induces progenitor cell proliferation J Neurosci 25 2005 1816 1825
30. E.L. Pacheco-Pantoja, L.R. Ranganath, J.A. Gallagher, P.J. Wilson, and W.D. Fraser Receptors and effects of gut hormones in three osteoblastic cell lines BMC Physiol 11 2011 12
31. R.J. Bollag, Q. Zhong, P. Phillips, L. Min, L. Zhong, R. Cameron, A.L. Mulloy, H. Rasmussen, F. Qin, and K.H. Ding Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors Endocrinology 141 2000 1228 1235
32. G. Mabilleau, C. Gaudin-Audrain, N. Irwin, P.R. Flatt, M.F. Basle, and D. Chappard Deficiency in glucose-dependent insulinotropic peptide receptor results in higher bone mass in male mice Osteoporos Int 23 2012 S407 S408
33. Q. Zhong, T. Itokawa, S. Sridhar, K.H. Ding, D. Xie, B. Kang, W.B. Bollag, R.J. Bollag, M. Hamrick, and K. Insogna Effects of glucose-dependent insulinotropic peptide on osteoclast function Am J Physiol Endocrinol Metab 292 2007 E543 E548
34. J.P. Fortin, J.C. Schroeder, Y. Zhu, M. Beinborn, and A.S. Kopin Pharmacological characterization of human incretin receptor missense variants J Pharmacol Exp Ther 332 2010 274 280
35. S.S. Torekov, T. Harslof, L. Rejnmark, P. Eiken, J.B. Jensen, A.P. Herman, T. Hansen, O. Pedersen, J.J. Holst, and B.L. Langdahl A functional amino acid substitution in the glucose-dependent insulinotropic polypeptide receptor (GIPR) gene is associated with lower bone mineral density and increased fracture risk J Clin Endocrinol Metab 99 2014 E729 E733
36. K. Miyawaki, Y. Yamada, H. Yano, H. Niwa, N. Ban, Y. Ihara, A. Kubota, S. Fujimoto, M. Kajikawa, and A. Kuroe Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice Proc Natl Acad Sci U S A 96 1999 14843 14847
37. F. Preitner, M. Ibberson, I. Franklin, C. Binnert, M. Pende, A. Gjinovci, T. Hansotia, D.J. Drucker, C. Wollheim, and R. Burcelin Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors J Clin Invest 113 2004 635 645
38. D. Xie, H. Cheng, M. Hamrick, Q. Zhong, K.H. Ding, D. Correa, S. Williams, A. Mulloy, W. Bollag, and R.J. Bollag Glucose-dependent insulinotropic polypeptide receptor knockout mice have altered bone turnover Bone 37 2005 759 769
39. K. Tsukiyama, Y. Yamada, C. Yamada, N. Harada, Y. Kawasaki, M. Ogura, K. Bessho, M. Li, N. Amizuka, and M. Sato Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion Mol Endocrinol 20 2006 1644 1651
40. C. Gaudin-Audrain, N. Irwin, S. Mansur, P.R. Flatt, B. Thorens, M. Basle, D. Chappard, and G. Mabilleau Glucose-dependent insulinotropic polypeptide receptor deficiency leads to modifications of trabecular bone volume and quality in mice Bone 53 2013 221 230
41. A. Mieczkowska, N. Irwin, P.R. Flatt, D. Chappard, and G. Mabilleau Glucose-dependent insulinotropic polypeptide (GIP) receptor deletion leads to reduced bone strength and quality Bone 56 2013 337 342
42. G. Mabilleau, A. Mieczkowska, N. Irwin, Y. Simon, M. Audran, P.R. Flatt, and D. Chappard Beneficial effects of a N-terminally modified GIP agonist on tissue-level bone material properties Bone 63 2014 61 68
43. Q. Zhong, K.H. Ding, A.L. Mulloy, R.J. Bollag, and C.M. Isales Glucose-dependent insulinotropic peptide stimulates proliferation and TGF-beta release from MG-63 cells Peptides 24 2003 611 616
44. R.J. Bollag, Q. Zhong, K.H. Ding, P. Phillips, L. Zhong, F. Qin, J. Cranford, A.L. Mulloy, R. Cameron, and C.M. Isales Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects Mol Cell Endocrinol 177 2001 35 41
45. A. Mieczkowska, B. Bouvard, D. Chappard, and G. Mabilleau Glucose-dependent insulinotropic polypeptide (GIP) directly affects collagen fibril diameter and collagen cross-linking in osteoblast cultures Bone 74 2015 29 36
46. A. Nissen, M. Christensen, F.K. Knop, T. Vilsboll, J.J. Holst, and B. Hartmann Glucose-dependent insulinotropic polypeptide inhibits bone resorption in humans J Clin Endocrinol Metab 99 2014 E2325 E2329
47. Y.C. Lee, P.L. Brubaker, and D.J. Drucker Developmental and tissue-specific regulation of proglucagon gene expression Endocrinology 127 1990 2217 2222
48. A.M. Habib, P. Richards, L.S. Cairns, G.J. Rogers, C.A. Bannon, H.E. Parker, T.C. Morley, G.S. Yeo, F. Reimann, and F.M. Gribble Overlap of endocrine hormone expression in the mouse intestine revealed by transcriptional profiling and flow cytometry Endocrinology 153 2012 3054 3065
49. J.J. Holst Gut glucagon, enteroglucagon, gut glucagonlike immunoreactivity, glicentin - current status Gastroenterology 84 1983 1602 1613
50. B. Hartmann, A.H. Johnsen, C. Orskov, K. Adelhorst, L. Thim, and J.J. Holst Structure, measurement, and secretion of human glucagon-like peptide-2 Peptides 21 2000 73 80
51. C. Orskov, L. Rabenhoj, A. Wettergren, H. Kofod, and J.J. Holst Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans Diabetes 43 1994 535 539
52. J.J. Holst, and C.F. Deacon Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors Diabetologia 48 2005 612 615
53. B. Thorens Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1 Proc Natl Acad Sci U S A 89 1992 8641 8645
54. C.H. McIntosh, S. Widenmaier, and S.J. Kim Pleiotropic actions of the incretin hormones Vitam Horm 84 2010 21 79
55. J. Clover, and M. Gowen Are MG-63 and HOS TE85 human osteosarcoma cell lines representative models of the osteoblastic phenotype? Bone 15 1994 585 591
56. B. Nuche-Berenguer, S. Portal-Nunez, P. Moreno, N. Gonzalez, A. Acitores, A. Lopez-Herradon, P. Esbrit, I. Valverde, and M.L. Villanueva-Penacarrillo Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor J Cell Physiol 225 2010 585 592
57. G. Mabilleau, A. Mieczkowska, N. Irwin, P.R. Flatt, and D. Chappard Optimal bone mechanical and material properties require a functional GLP-1 receptor J Endocrinol 219 2013 59 68
58. M.A. Luque, N. Gonzalez, L. Marquez, A. Acitores, A. Redondo, M. Morales, I. Valverde, and M.L. Villanueva-Penacarrillo Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes J Endocrinol 173 2002 465 473
59. M.L. Villanueva-Penacarrillo, E. Delgado, M.A. Trapote, A. Alcantara, F. Clemente, M.A. Luque, A. Perea, and I. Valverde Glucagon-like peptide-1 binding to rat hepatic membranes J Endocrinol 146 1995 183 189
60. J.Y. Kim, S.K. Lee, K.J. Jo, D.Y. Song, D.M. Lim, K.Y. Park, L.F. Bonewald, and B.J. Kim Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes Life Sci 92 2013 533 540
61. N. Panjwani, E.E. Mulvihill, C. Longuet, B. Yusta, J.E. Campbell, T.J. Brown, C. Streutker, D. Holland, X. Cao, and L.L. Baggio GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-/-) mice Endocrinology 154 2013 127 139
62. C. Pyke, R.S. Heller, R.K. Kirk, C. Orskov, S. Reedtz-Runge, P. Kaastrup, A. Hvelplund, L. Bardram, D. Calatayud, and L.B. Knudsen GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody Endocrinology 155 2014 1280 1290
63. C. Pyke, and L.B. Knudsen The glucagon-like peptide-1 receptor - or not? Endocrinology 154 2013 4 8
64. C. Yamada, Y. Yamada, K. Tsukiyama, K. Yamada, N. Udagawa, N. Takahashi, K. Tanaka, D.J. Drucker, Y. Seino, and N. Inagaki The murine glucagon-like peptide-1 receptor is essential for control of bone resorption Endocrinology 149 2008 574 579
65. L.W. Madsen, J.A. Knauf, C. Gotfredsen, A. Pilling, I. Sjogren, S. Andersen, L. Andersen, A.S. de Boer, K. Manova, and A. Barlas GLP-1 receptor agonists and the thyroid: C-cell effects in mice are mediated via the GLP-1 receptor and not associated with RET activation Endocrinology 153 2012 1538 1547
66. B. Nuche-Berenguer, P. Moreno, P. Esbrit, S. Dapia, J.R. Caeiro, J. Cancelas, J.J. Haro-Mora, and M.L. Villanueva-Penacarrillo Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states Calcif Tissue Int 84 2009 453 461
67. B. Nuche-Berenguer, P. Moreno, S. Portal-Nunez, S. Dapia, P. Esbrit, and M.L. Villanueva-Penacarrillo Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states Regul Pept 159 2010 61 66
68. X. Ma, J. Meng, M. Jia, L. Bi, Y. Zhou, Y. Wang, J. Hu, G. He, and X. Luo Exendin-4, a glucagon-like peptide-1 receptor agonist, prevents osteopenia by promoting bone formation and suppressing bone resorption in aged ovariectomized rats J Bone Miner Res 28 2013 1641 1652
69. A. Mizokami, Y. Yasutake, J. Gao, M. Matsuda, I. Takahashi, H. Takeuchi, and M. Hirata Osteocalcin induces release of glucagon-like peptide-1 and thereby stimulates insulin secretion in mice PLoS One 8 2013 e57375
70. A. Mizokami, Y. Yasutake, S. Higashi, T. Kawakubo-Yasukochi, S. Chishaki, I. Takahashi, H. Takeuchi, and M. Hirata Oral administration of osteocalcin improves glucose utilization by stimulating glucagon-like peptide-1 secretion Bone 69 2014 68 79
71. G. Mabilleau, A. Mieczkowska, and D. Chappard Use of glucagon-like peptide-1 receptor agonists and bone fractures: a meta-analysis of randomized clinical trials J Diabetes 6 2014 260 266